These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1720700)

  • 21. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Mayani H; Baines P; Bowen DT; Jacobs A
    Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
    Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
    Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased proliferation of eosinophil clusters in myelodysplastic syndromes.
    Koike M; Ishiyama T; Yokoyama A; Kawakami K; Nakamaki T; Tomoyasu S; Tsuruoka N
    Leuk Res; 1995 Dec; 19(12):915-20. PubMed ID: 8632660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
    Sakamoto KM; Gasson JC
    Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A; Shibata A
    Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia.
    Guinan EC; Sieff CA; Oette DH; Nathan DG
    Blood; 1990 Sep; 76(6):1077-82. PubMed ID: 2205306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.
    Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R
    Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.
    Welte K; Zeidler C; Reiter A; Müller W; Odenwald E; Souza L; Riehm H
    Blood; 1990 Mar; 75(5):1056-63. PubMed ID: 1689595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors.
    Nemunaitis J; Anasetti C; Storb R; Bianco JA; Buckner CD; Onetto N; Martin P; Sanders J; Sullivan K; Mori M
    Blood; 1992 May; 79(10):2572-7. PubMed ID: 1586709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
    Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J
    Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
    Gianni AM; Bregni M; Siena S; Magni M; Di Nicola M; Lombardi F; Tarella C; Pileri A; Bonadonna G
    J Clin Oncol; 1992 Dec; 10(12):1955-62. PubMed ID: 1280674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).
    Yoshida Y; Asano S; Hirashima K; Takaku F
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():349-52. PubMed ID: 1284304
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants.
    Blazar BR; Aukerman SL; Vallera DA
    Blood; 1992 Mar; 79(6):1636-42. PubMed ID: 1547353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
    Katayama K; Koizumi S; Ueno Y; Ohno I; Ichihara T; Horita S; Miyawaki T; Taniguchi N
    Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased frequency of bone marrow NK progenitors in aplastic anaemia.
    Yoda Y; Kawakami Z; Abe T
    Br J Haematol; 1989 Apr; 71(4):545-9. PubMed ID: 2713273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH; Smith BR; Holmes W; David RN; Rosenthal S
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.
    Nawata J; Toyoda Y; Nisihira H; Honda K; Kigasawa H; Nagao T
    Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.